Bioterror Bill Needs Specific Animal Study Rx Approval Language, Hatch Says
Executive Summary
Congress should specify the conditions under which bioterrorism products may be approved based on animal studies, Sen. Orrin Hatch (R-Utah) said
You may also be interested in...
FDA Animal Efficacy Rule Needs To Be Codified In Bioterror Bill – Hatch
Sen. Orrin Hatch (R-Utah) is pushing for changes to the bioterrorism conference bill that would codify FDA's animal efficacy rule, he told a Food & Drug Law Institute meeting in Washington, D.C., April 15
FDA Animal Efficacy Rule Needs To Be Codified In Bioterror Bill – Hatch
Sen. Orrin Hatch (R-Utah) is pushing for changes to the bioterrorism conference bill that would codify FDA's animal efficacy rule, he told a Food & Drug Law Institute meeting in Washington, D.C., April 15
Rx Import Controls Included In Tauzin/Dingell Bioterrorism Bill
The House Energy & Commerce Committee bioterrorism bill would increase controls on the importation of pharmaceuticals